Call it a case of bad timing for Indian stock bulls. Donald Trump has dealt two fresh blows to investor sentiment just as the market was showing signs of a turnaround.
The MSCI India Index has fallen in all five sessions since the US President signed an order to overhaul the H-1B visa program — a move that risks disrupting India’s $280 billion software services industry. His plan to impose a 100% duty on branded or patented pharmaceuticals saw Indian drugmakers join an Asia-wide selloffBloomberg Terminal on Friday.